EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, SABS: Sab Biotherapeutics Inc

12 Oct 26 15:59
LAST:

2.825

CHANGE:
 0.15		OPEN:
2.950		HIGH:
3.000		ASK:
0.000		VOLUME:
260.6K
CHG(%):
5.03		PREV:
2.980		LOW:
2.800		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
12 Oct 262.9903.0002.8002.830358.9K
09 Oct 262.9003.0202.8102.980659.6K
08 Oct 262.8502.9302.7602.8901.14M
07 Oct 262.9002.9652.8102.880681.6K
06 Oct 263.1203.1602.9152.930663.6K
05 Oct 263.0003.2502.8553.100866.2K
02 Oct 263.1003.1202.9602.980416.3K
01 Oct 263.1703.2253.0403.060324.9K
30 Sep 263.2303.4003.1603.170487.7K
29 Sep 263.2403.3103.1903.2201.06M

PROFILE

Name:Sab Biotherapeutics Inc
About:SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders. It has applied advanced genetic engineering to develop transchromosomic for hyperimmunization and plasma collection, as well as develops product to treat diseases, including type 1 diabetes (T1D) and other autoimmune disorders. In addition, its lead product candidate SAB-142, a human, multi-target anti-thymocyte globulin treatment, currently under Phase 2b clinical trials in delaying the onset or progression of type 1. SAB Biotherapeutics, Inc. was founded in 2014 and is headquartered in Miami Beach, Florida.
Sector:Healthcare
Industry:Biotechnology
Address:777 W 41st St., Miami Beach, FL, United States, 33140
Website:https://www.sabbiotherapeutics.com
CUSIP:78397T103
CIK:0001833214
ISIN:US78397T1034
FIGI:BBG00YHY0G24

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:12.42 
Forward P/E:-3.12 
Price to Sales:186.98 
Price to Book:1.16 
EPS Ratio:0.24 
Revenue:114.7K 
Shares:90.99M 
Market Cap:257.04M 

TECHNICAL INDICATORS

MA5:2.902.7%
MA10:3.006.3%
MA20:3.2013.2%
MA50:3.5224.4%
MA100:3.5927.0%
MA200:3.7532.6%
RSI14:20.09 
WPR14:-100.00 
MTM14:-0.56
ROC14:-0.17 
ATR:0.21 
Week High:3.2515.0%
Week Low:2.762.4%
Month High:3.5726.2%
Month Low:2.7632.6%
Year High:5.1582.3%
Year Low:2.1034.5%

RECENT SPLITS

Date Ratio
05 Jan 20241-10